In addition, in the M445T allele carriers, a higher LDL-C lowering response to atorvastatin was detected among 340 Americans suffering from primary hypercholesterolemia, although it failed to reach statistical significance [ 24 , 34 ].
← all excerpts
Association between CYP3A4/CYP3A5 genetic polymorphisms and treatment outcomes of atorvastatin worldwide: is there enough research on the Egyptian population?
1
—
—